Urinary tamm-horsfall protein increased after potassium citrate therapy in calcium stone formers
- 1 June 1995
- Vol. 45 (6) , 942-946
- https://doi.org/10.1016/s0090-4295(99)80112-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Calcium Oxalate Stone Agglomeration Reflects Stone-Forming Activity: Citrate Inhibition Depends on Macromolecules Larger Than 30 KilodaltonAmerican Journal of Kidney Diseases, 1994
- Tamm-Horsfall glycoprotein-inhibitor or promoter of calcium oxalate monohydrate crystallization processes?Urological Research, 1992
- Reduction in the anti-adherence activity of Tamm-Horsfall protein with increasing concentration of calciumUrological Research, 1991
- Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine?Clinica Chimica Acta; International Journal of Clinical Chemistry, 1990
- Crystal agglomeration is a major element in calcium oxalate urinary stone formationKidney International, 1990
- Possible Role of Tamm‐Horsfall Glycoprotein in Calcium Oxalate CrystallisationBritish Journal of Urology, 1989
- Modifiers of Calcium Oxalate Crystallization Found in Urine. III. Studies on the Role of Tamm-Horsfall Mucoprotein and of Ionic StrengthJournal of Urology, 1986
- EXCESSIVE CRYSTAL AGGLOMERATION WITH LOW CITRATE EXCRETION IN RECURRENT STONE-FORMERSThe Lancet, 1986
- Urinary Tamm—Horsfall Glycoprotein in Certain Kidney Diseases and its Content in Renal and Bladder CalculiClinical Science, 1973
- Determination of citrate with citrate lyaseAnalytical Biochemistry, 1966